While serum levels of IGF decrease with age, within the aged population those individuals with the highest levels of serum IGF-1 have the greatest risk of developing epithelial cancers such as prostate cancer (Kaplan et al, 1999). This evidence concerns the gene IGF1 and prostate carcinoma.